BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20872293)

  • 1. Hepatocellular carcinoma in non-cirrhotic liver without evidence of iron overload in a patient with primary hemochromatosis. Review.
    Singh P; Kaur H; Lerner RG; Patel R; Rafiyath SM; Singh Lamba G
    J Gastrointest Cancer; 2012 Mar; 43(1):36-9. PubMed ID: 20872293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.
    Blumberg RS; Chopra S; Ibrahim R; Crawford J; Farraye FA; Zeldis JB; Berman MD
    Gastroenterology; 1988 Nov; 95(5):1399-402. PubMed ID: 2844622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis.
    Britto MR; Thomas LA; Balaratnam N; Griffiths AP; Duane PD
    Scand J Gastroenterol; 2000 Aug; 35(8):889-93. PubMed ID: 10994630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
    Mogl MT; Pascher A; Presser SJ; Schwabe M; Neuhaus P; Nuessler NC
    World J Gastroenterol; 2007 Apr; 13(13):1998-2001. PubMed ID: 17461505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis.
    Tomao S; Romiti A; Mozzicafreddo A; Raffaele M; Zullo A; Antonaci A
    Oncol Rep; 1998; 5(3):723-5. PubMed ID: 9538184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
    von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
    Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis].
    Pellisé M; González-Abraldes J; Navasa M; Miquel R; Bruguera M
    Gastroenterol Hepatol; 2001 Mar; 24(3):132-4. PubMed ID: 11261224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.
    Yamauchi R; Takata K; Shinagawa Y; Tanaka T; Fukuda H; Fukuda S; Kunimoto H; Umeda K; Morihara D; Yokoyama K; Takeyama Y; Irie M; Shakado S; Mizoguchi M; Hisano S; Yoshimitsu K; Sakisaka S
    Intern Med; 2019 Mar; 58(5):661-665. PubMed ID: 30449774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis.
    Fellows IW; Stewart M; Jeffcoate WJ; Smith PG; Toghill PJ
    Gut; 1988 Nov; 29(11):1603-6. PubMed ID: 2850272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
    Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
    Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.
    Beaton MD; Adams PC
    Can J Gastroenterol; 2006 Apr; 20(4):257-60. PubMed ID: 16609753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.
    Harrison SA; Bacon BR
    Med Clin North Am; 2005 Mar; 89(2):391-409. PubMed ID: 15656932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort: A prospective longitudinal observational study.
    Nowak A; Giger RS; Krayenbuehl PA
    Medicine (Baltimore); 2018 Oct; 97(42):e12886. PubMed ID: 30335010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective altruistic phlebotomy: hereditary haemochromatosis presenting as hepatocellular carcinoma in a non-cirrhotic 83-year-old man.
    Ooka K; Onyiuke I; Zhang X; Taddei TH
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27591041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for hepatocellular carcinoma arising in hereditary hemochromatosis.
    Sotiropoulos GC; Molmenti EP; Lang H; Beckebaum S; Kaiser GM; Brokalaki EI; Frilling A; Malagó M; Neuhauser M; Broelsch CE
    Eur Surg Res; 2006; 38(4):371-6. PubMed ID: 16837807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis.
    Hiatt T; Trotter JF; Kam I
    Am J Med Sci; 2007 Sep; 334(3):228-30. PubMed ID: 17873542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma presenting as a pyogenic liver abscess in a patient with hemochromatosis.
    Yang YH; Chen CC; Chiang JH; Kung SP; Tsay SH; Wang SS; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):53-7. PubMed ID: 10645051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron in the pathogenesis of hepatocellular carcinoma.
    Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
    Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and hepatocellular carcinoma.
    Deugnier Y; Turlin B
    J Gastroenterol Hepatol; 2001 May; 16(5):491-4. PubMed ID: 11350542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.